Researchers report that the weight loss drugs semaglutide and tirzepatide can reduce the risk of hospitalization and death by 40% in people with a common type of heart failure. Experts say this large ...

An international clinical trial has found that an oral form of semaglutide, a widely used diabetes drug, reduced the risk of serious heart failure events in people with type 2 diabetes who already had ...

A weight loss medication is showing remarkable promise in treating one of America’s most serious health conditions. New research reveals that Zepbound, already celebrated for its effectiveness in ...

New drugs and a growing awareness of the common condition offer hope for patients. By Nina Agrawal Ann Ramirez first noticed something was wrong when, at age 48, she started waking up in the middle of ...

While proven to help, primary care clinicians have been slow to use the drugs once considered only for patients with diabetes.

Commonly used medications and nutritional supplements may cause or worsen heart failure, according to the first scientific statement from the American Heart Association to provide guidance on avoiding ...

CHICAGO — A nasal spray formulation of bumetanide, a diuretic drug, could help treat heart failure by preventing the resistance that can develop to oral forms of the drug, a preliminary safety and ...

A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research from the University of East Anglia. Many cancer patients go on to develop ...

Researchers report that the weight loss drugs semaglutide and tirzepatide can reduce the risk of hospitalization and death by 40% in people with a common type of heart failure. Experts say this large ...